Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Chem Biol Drug Des] 2024 Feb; Vol. 103 (2), pp. e14431.
- MeSH Terms: Flavonoids* / pharmacology ; Mesenchymal Stem Cells* / cytology ; Mesenchymal Stem Cells* / drug effects ; Mesenchymal Stem Cells* / metabolism ; Osteogenesis* / drug effects ; Osteogenesis* / genetics ; Sirtuin 1* / genetics ; Sirtuin 1* / metabolism ; Humans ; beta Catenin / metabolism ; Cell Differentiation / drug effects ; Cells, Cultured ; Ubiquitin Thiolesterase / metabolism ; Ubiquitin-Specific Proteases / metabolism ; Gene Knockdown Techniques
- References: Bi, Z., Zhang, W., & Yan, X. (2022). Anti-inflammatory and immunoregulatory effects of icariin and icaritin. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 151, 113180. https://doi.org/10.1016/j.biopha.2022.113180. ; Chen, Y., Zhou, F., Liu, H., Li, J., Che, H., Shen, J., & Luo, E. (2021). SIRT1, a promising regulator of bone homeostasis. Life Sciences, 269, 119041. https://doi.org/10.1016/j.lfs.2021.119041. ; Chu, D. T., Phuong, T. N. T., Tien, N. L. B., Tran, D. K., Thanh, V. V., Quang, T. L., Truong, D. T., Pham, V. H., Ngoc, V. T. N., Chu-Dinh, T., & Kushekhar, K. (2020). An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem/stromal cells. International Journal of Molecular Sciences, 21(3), 708. https://doi.org/10.3390/ijms21030708. ; Deng, X., Deng, L., Xu, M., Sun, Y., & Yang, M. (2023). Effects of SIRT1 on osteogenic differentiation of bone marrow mesenchymal stem cells in type 2 diabetic patients. Endocrine, Metabolic & Immune Disorders Drug Targets, 23, 1077-1086. https://doi.org/10.2174/1871530323666230109124631. ; Feng, G., Zheng, K., Song, D., Xu, K., Huang, D., Zhang, Y., Cao, P., Shen, S., Zhang, J., Feng, X., & Zhang, D. (2016). SIRT1 was involved in TNF-alpha-promoted osteogenic differentiation of human DPSCs through Wnt/beta-catenin signal. In Vitro Cellular & Developmental Biology. Animal, 52, 1001-1011. https://doi.org/10.1007/s11626-016-0070-9. ; Fu, Y., Zhan, X., You, X., Nie, D., Mai, H., Chen, Y., He, S., Sheng, J., Zeng, Z., Li, H., Li, J., & Hu, S. (2023). USP12 promotes antiviral responses by deubiquitinating and stabilizing IFI16. PLoS Pathogens, 19, e1011480. https://doi.org/10.1371/journal.ppat.1011480. ; Guo, Q., Liu, Y., Sun, R., Yang, F., Qiao, P., Zhang, R., Song, L., Lingling, E., & Liu, H. (2020). Mechanical stimulation induced osteogenic differentiation of BMSCs through TWIST/E2A/p21 axis. Bioscience Reports, 40, BSR20193876. https://doi.org/10.1042/BSR20193876. ; Guo, Y., Cui, S., Chen, Y., Guo, S., & Chen, D. (2023). Ubiquitin specific peptidases and prostate cancer. PeerJ, 11, e14799. https://doi.org/10.7717/peerj.14799. ; Huang, P., Wang, F., Zhang, Y., Zhang, Y., Qin, M., Ji, J., Wei, D., & Ren, L. (2023). Icariin alleviates atherosclerosis by regulating the miR-205-5p/ERBB4/AKT signaling pathway. International Immunopharmacology, 114, 109611. https://doi.org/10.1016/j.intimp.2022.109611. ; Huang, Z., Wei, H., Wang, X., Xiao, J., Li, Z., Xie, Y., Hu, Y., Li, X., Wang, Z., & Zhang, S. (2020). Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling. Molecular Medicine Reports, 21, 1590-1596. https://doi.org/10.3892/mmr.2020.10954. ; Kassel, S., Hanson, A. J., Benchabane, H., Saito-Diaz, K., Cabel, C. R., Goldsmith, L., Taha, M., Kanuganti, A., Ng, V. H., Xu, G., Ye, F., Picker, J., Port, F., Boutros, M., Weiss, V. L., Robbins, D. J., Thorne, C. A., Ahmed, Y., & Lee, E. (2023). USP47 deubiquitylates Groucho/TLE to promote Wnt-beta-catenin signaling. Science Signaling, 16, eabn8372. https://doi.org/10.1126/scisignal.abn8372. ; Li, Y., Nie, J., Wu, Q., Yang, X., & Jiang, P. (2023). Circ-Sirt1 promotes osteoblast differentiation by activating Sirt1 and Wnt/beta-catenin pathway. Acta Biochimica Polonica, 70, 51-57. https://doi.org/10.18388/abp.2020_6035. ; Liu, H., Yi, X., Tu, S., Cheng, C., & Luo, J. (2021). Kaempferol promotes BMSC osteogenic differentiation and improves osteoporosis by downregulating miR-10a-3p and upregulating CXCL12. Molecular and Cellular Endocrinology, 520, 111074. https://doi.org/10.1016/j.mce.2020.111074. ; Liu, J., Han, W., Chen, L., & Tang, K. (2016). Mechanism of osteogenic and adipogenic differentiation of tendon stem cells induced by sirtuin 1. Molecular Medicine Reports, 14, 1643-1648. https://doi.org/10.3892/mmr.2016.5417. ; Mohamed-Ahmed, S., Fristad, I., Lie, S. A., Suliman, S., Mustafa, K., Vindenes, H., & Idris, S. B. (2018). Adipose-derived and bone marrow mesenchymal stem cells: A donor-matched comparison. Stem Cell Research & Therapy, 9, 168. https://doi.org/10.1186/s13287-018-0914-1. ; Mooney, E. C., & Sahingur, S. E. (2021). The ubiquitin system and A20: Implications in health and disease. Journal of Dental Research, 100, 10-20. https://doi.org/10.1177/0022034520949486. ; Pan, B., Yang, Y., Li, J., Wang, Y., Fang, C., Yu, F. X., & Xu, Y. (2020). USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein & Cell, 11, 138-143. https://doi.org/10.1007/s13238-019-00674-w. ; Peng, J., Li, W., Tan, N., Lai, X., Jiang, W., & Chen, G. (2022). USP47 stabilizes BACH1 to promote the Warburg effect and non-small cell lung cancer development via stimulating Hk2 and Gapdh transcription. American Journal of Cancer Research, 12, 91-107. ; Qin, B., Zhou, L., Wang, F., & Wang, Y. (2022). Ubiquitin-specific protease 20 in human disease: Emerging role and therapeutic implications. Biochemical Pharmacology, 206, 115352. https://doi.org/10.1016/j.bcp.2022.115352. ; Shen, G., Ren, H., Shang, Q., Zhao, W., Zhang, Z., Yu, X., Tang, K., Tang, J., Yang, Z., Liang, D., & Jiang, X. (2020). Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/beta-catenin signalling pathway and prevents ovariectomy-induced bone loss. eBioMedicine, 52, 102626. https://doi.org/10.1016/j.ebiom.2020.102626. ; Shen, J., Lin, X., Dai, F., Chen, G., Lin, H., Fang, B., & Liu, H. (2023). Ubiquitin-specific peptidases: Players in bone metabolism. Cell Proliferation, 56, e13444. https://doi.org/10.1111/cpr.13444. ; Shen, P., Deng, X., Chen, Z., Ba, X., Qin, K., Huang, Y., Huang, Y., Li, T., Yan, J., & Tu, S. (2021). SIRT1: A potential therapeutic target in autoimmune diseases. Frontiers in Immunology, 12, 779177. https://doi.org/10.3389/fimmu.2021.779177. ; Wang, H., Hu, Z., Wu, J., Mei, Y., Zhang, Q., Zhang, H., Miao, D., & Sun, W. (2019). Sirt1 promotes osteogenic differentiation and increases alveolar bone mass via Bmi1 activation in mice. Journal of Bone and Mineral Research, 34, 1169-1181. https://doi.org/10.1002/jbmr.3677. ; Wang, K., Zhao, Z., Wang, X., & Zhang, Y. (2021). BRD4 induces osteogenic differentiation of BMSCs via the Wnt/beta-catenin signaling pathway. Tissue & Cell, 72, 101555. https://doi.org/10.1016/j.tice.2021.101555. ; Wang, Z., Wang, D., Yang, D., Zhen, W., Zhang, J., & Peng, S. (2018). The effect of icariin on bone metabolism and its potential clinical application. Osteoporosis International, 29, 535-544. https://doi.org/10.1007/s00198-017-4255-1. ; Xia, S. L., Ma, Z. Y., Wang, B., Gao, F., Guo, S. Y., & Chen, X. H. (2023). Icariin promotes the proliferation and osteogenic differentiation of bone-derived mesenchymal stem cells in patients with osteoporosis and T2DM by upregulating GLI-1. Journal of Orthopaedic Surgery and Research, 18, 500. https://doi.org/10.1186/s13018-023-03998-w. ; Xiao, Q., Tang, Y., Xia, J., Luo, H., Yu, M., Chen, S., Wang, W., Pu, L., Wang, L., Li, G., & Li, Y. (2022). Ubiquitin-specific protease 47 is associated with vascular calcification in chronic kidney disease by regulating osteogenic transdifferentiation of vascular smooth muscle cells. Renal Failure, 44, 752-766. https://doi.org/10.1080/0886022X.2022.2072337. ; Yan, W., Li, L., Ge, L., Zhang, F., Fan, Z., & Hu, L. (2022). The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition. Stem Cell Research & Therapy, 13, 22. https://doi.org/10.1186/s13287-022-02702-9. ; Yang, Y., Liu, Y., Wang, Y., Chao, Y., Zhang, J., Jia, Y., Tie, J., & Hu, D. (2022). Regulation of SIRT1 and its roles in inflammation. Frontiers in Immunology, 13, 831168. https://doi.org/10.3389/fimmu.2022.831168. ; Yao, H., Yao, Z., Zhang, S., Zhang, W., & Zhou, W. (2018). Upregulation of SIRT1 inhibits H2O2-induced osteoblast apoptosis via FoxO1/beta-catenin pathway. Molecular Medicine Reports, 17, 6681-6690. https://doi.org/10.3892/mmr.2018.8657. ; Young, M. J., Hsu, K. C., Lin, T. E., Chang, W. C., & Hung, J. J. (2019). The role of ubiquitin-specific peptidases in cancer progression. Journal of Biomedical Science, 26, 42. https://doi.org/10.1186/s12929-019-0522-0. ; Zhang, F., Yin, Y., Xu, W., Song, Y., Zhou, Z., Sun, X., & Li, P. (2022). Icariin inhibits gastric cancer cell growth by regulating the hsa_circ_0003159/miR-223-3p/NLRP3 signaling axis. Human & Experimental Toxicology, 41, 9603271221097363. https://doi.org/10.1177/09603271221097363. ; Zhang, X. Y., Li, H. N., Chen, F., Chen, Y. P., Chai, Y., Liao, J. Z., Gan, B., Chen, D. P., Li, S., & Liu, Y. Q. (2021). Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/beta-catenin pathways in osteonecrosis of the femoral head. Saudi pharmaceutical journal, 29, 1405-1415. https://doi.org/10.1016/j.jsps.2021.10.009. ; Zhu, C., Ding, H., Shi, L., Zhang, S., Tong, X., Huang, M., Liu, L., Guan, X., Zou, J., Yuan, Y., & Chen, X. (2023). Exercise improved bone health in aging mice: A role of SIRT1 in regulating autophagy and osteogenic differentiation of BMSCs. Frontiers in Endocrinology, 14, 1156637. https://doi.org/10.3389/fendo.2023.1156637.
- Contributed Indexing: Keywords: BMSCs; Icariin; SIRT1; USP47; osteogenic differentiation
- Substance Nomenclature: 0 (beta Catenin) ; 0 (Flavonoids) ; VNM47R2QSQ (icariin) ; EC 3.5.1.- (SIRT1 protein, human) ; EC 3.5.1.- (Sirtuin 1) ; 0 (USP47 protein, human) ; EC 3.4.19.12 (Ubiquitin Thiolesterase) ; EC 3.4.19.12 (Ubiquitin-Specific Proteases)
- Entry Date(s): Date Created: 20240219 Date Completed: 20240223 Latest Revision: 20240325
- Update Code: 20240325
|